Lower lip squamous cell carcinoma in patients with photosensitive disorders: Analysis of cases treated at the Brazilian National Cancer Institute (INCA) from 1999 to 2012

被引:3
|
作者
Borges, Jorena-Fraga-Pimenta [1 ]
Nattalia-Di Lanaro [2 ]
Bernardo, Vagner-Goncalves [3 ]
Albano, Rodolpho-Mattos [3 ]
Dias, Fernando [4 ]
de Faria, Paulo-Antonio-Silvestre [5 ]
Pinto, Luis-Felipe-Ribeiro [2 ]
Lourenco, Simone-de Queiroz-Chaves [6 ]
机构
[1] Inst Nacl Canc INCA, Programa Residencia Multiprofiss Odontol Oncol, Rio De Janeiro, Brazil
[2] Inst Nacl Canc INCA, Programa Carcinogenese Mol CPQ, Rio De Janeiro, Brazil
[3] Univ Estado Rio de Janeiro UERJ, Dept Bioquim, Rio De Janeiro, Brazil
[4] Inst Nacl Canc INCA, Dept Cirurgia Cabeca & Pescoco, Rio De Janeiro, Brazil
[5] Inst Nacl Canc INCA, Div Patol, Rio De Janeiro, Brazil
[6] Univ Fed Fluminense, Programa Posgrad Odontol, Niteroi, RJ, Brazil
来源
关键词
Lip cancer; Xeroderma Pigmentosum; Albinism; Lupus erythematosus; DISCOID LUPUS-ERYTHEMATOSUS; EXPRESSION;
D O I
10.4317/medoral.21960
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background: Lower lip squamous cell carcinoma (LLSCC) is a common malignancy of the head and neck, being mainly a consequence of a chronic exposure to ultraviolet (UV) light solar radiation. Here, we evaluated the clinicopathological profile of patients with photosensitive disorders (xeroderma pigmentosum, lupus erythematosus and albinism) that developed LLSCC. Material and Methods: Data from patients who had a diagnosed LLSCC with a prior xeroderma pigmentosum, lupus erythematosus or albinism diagnosis that were treated at INCA from 1999 to 2012 were collected from patients' medical records (n=16). The control group was composed of 68 patients with LLSCC without a medical history of photosensitivity. The clinicopathological data of this study population were collected and the association between these variables was analyzed by Fisher's exact test. Survival curves were constructed using the Kaplan-Meier method and compared by log-rank test. All statistical analyses were performed using SPSS statistics package. Results: The mean age of patients in the photosensitive and non-photosensitive groups was 42 years and 67 years, respectively (p<0.0001). A previous history of malignant diseases was more common in the photosensitive group (p=0.001). In both groups, most tumors showed a pathological stage I/II disease. Overall and cancer-specific survival were not statistically different. However, disease-free interval showed a significant difference (p=0.01) between the photosensitive and non-photosensitive patients. Conclusions: Photosensitive patients presented LLSCC at earlier age but it usually was not the primary tumor in these patients. Furthermore, a more aggressive pathological behavior was not seen when compared with tumors from non-photosensitive patients. The disease-free interval was lower in photosensitive patients, as expected.
引用
收藏
页码:E7 / E12
页数:6
相关论文
共 50 条
  • [11] Efficacy of doxorubicin after progression on carboplatin and paclitaxel in advanced or recurrent endometrial cancer: a retrospective analysis of patients treated at the Brazilian National Cancer Institute (INCA)
    Moreira, Emeline
    Paulino, Eduardo
    Ingles Garces, Alvaro Henrique
    Fontes Dias, Mariane S.
    Saramago, Marcos
    Lino da Silva, Flora de Moraes
    Santos Thuler, Luiz Claudio
    de Melo, Andreia Cristina
    MEDICAL ONCOLOGY, 2018, 35 (03)
  • [12] Efficacy of doxorubicin after progression on carboplatin and paclitaxel in advanced or recurrent endometrial cancer: a retrospective analysis of patients treated at the Brazilian National Cancer Institute (INCA)
    Emeline Moreira
    Eduardo Paulino
    Álvaro Henrique Ingles Garces
    Mariane S. Fontes Dias
    Marcos Saramago
    Flora de Moraes Lino da Silva
    Luiz Claudio Santos Thuler
    Andréia Cristina de Melo
    Medical Oncology, 2018, 35
  • [13] Definitive chemoradiation with carboplatin and paclitaxel in locally advanced esophageal carcinoma: A retrospective analysis at the Brazilian National Cancer Institute (INCA).
    Araujo, Kelly Borges
    Siqueira, Mariana Bruno
    de Farias, Joao Paulo Fogacci
    Gil, Roberto Almeida
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [14] Prevalence of human papilloma virus in oropharyngeal, tongue and lip squamous cell carcinoma: an experience from the Egyptian National Cancer Institute
    Tealab, Safy Hosny
    Sedhom, Nevine F. H.
    Hassouna, Ashraf
    Gouda, Iman
    Ismail, Hoda
    JOURNAL OF INVESTIGATIVE MEDICINE, 2019, 67 (07) : 1061 - 1066
  • [15] METASTASES FROM SQUAMOUS-CELL CARCINOMA OF THE SKIN AND LIP - AN ANALYSIS OF 27 CASES
    DINEHART, SM
    POLLACK, SV
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1989, 21 (02) : 241 - 248
  • [16] Clinical Characteristics and Survival of Patients with Hairy Cell Leukemia Treated at the National Cancer Institute in Peru from 1999 to 2018
    Pena, Estefania
    Vasquez, Jule
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S399 - S400
  • [17] Surgical treatment of invasive squamous cell carcinoma of the penis:: Brazilian National Cancer Institute long-term experience
    Ornellas, Antonio Augusto
    Kinchin, Eduardo Wei
    Braga Nobrega, Bernardo Lindenberg
    Wisnescky, Aristoteles
    Koifman, Nelson
    Quirino, Raul
    JOURNAL OF SURGICAL ONCOLOGY, 2008, 97 (06) : 487 - 495
  • [18] Sentinel Lymph Node Biopsy in Patients With Acral Melanoma: Analysis of 201 Cases From the Brazilian National Cancer Institute
    Nunes, Luiz Fernando
    Mendes, Gelcio L. Q.
    Koifman, Rosalina J.
    DERMATOLOGIC SURGERY, 2019, 45 (08) : 1026 - 1034
  • [19] Surgical Treatment of Invasive Squamous Cell Carcinoma of the Penis: Brazilian National Cancer Institute Long-Term Experience
    Ornellas, A. A.
    Kinchin, E. W.
    Nobrega, B. L.
    Wisnescky, A.
    Koifman, N.
    Quirino, R.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 1692 - 1693
  • [20] Incidence and Survival of Patients with Waldenstrom Macroglobulinemia Treated at The National Cancer Institute in Peru from 1999 to 2018
    Vasquez, Jule
    Pena, Estefania
    Poquioma, Ebert
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S400 - S400